Latest Regulatory Clearance News

Osteopore Limited has completed another incremental drawdown of A$250,000 on the second tranche of its redeemable convertible notes, continuing its steady funding progress under a A$20 million subscription agreement with Advance Opportunities Fund.

The a2 Milk Company has clinched final Chinese regulatory approval to rebrand infant formula products under its flagship a2™ label, completing a pivotal acquisition step. The company plans to launch these products later in 2026 and is poised to declare a $300 million special dividend.

The Australian Competition and Consumer Commission has signalled no objection to Rubik Australia's full acquisition of Qube Holdings, paving the way for the scheme's next legal and regulatory steps. The Qube board also plans a fully franked special dividend, contingent on scheme approval.

Qube Holdings has postponed its second court hearing for the $5.20-per-share takeover by Rubik Australia, awaiting key regulatory approvals. The company plans to proceed with shareholder meetings and intends to pay a fully franked special dividend if the scheme proceeds.

Elders Limited has secured final regulatory approvals from FIRB and ACCC to complete the sale of Killara Feedlot to Australian Meat Group, with transaction completion anticipated by the end of June.

Heartland Group Holdings has satisfied all initial conditions for its acquisition of TSB Bank shares from Toi Foundation, moving closer to a December 2026 merger that will create TSB Heartland Bank Limited.

Horizon Oil confirms its takeover offer for Cue Energy shares as best and final, holding a majority stake and with all regulatory approvals cleared. The offer period closes on 19 June 2026, with liquidity risks flagged for minority shareholders who abstain.

Diamond Infraco has officially satisfied multiple regulatory conditions in its takeover offer for Atlas Arteria, freeing the offer from several major hurdles and holding a 34.56% stake.

ReNerve Limited has appointed UG Medical to distribute its NervAlign nerve repair products in Malaysia, tapping into a fast-growing healthcare market backed by government investment.

Heartland Group Holdings has agreed to acquire TSB Bank for NZD 620 million, merging the two into a challenger bank with $18 billion in assets and expected 20% EPS accretion.

Optiscan and Mayo Clinic have completed all key engineering milestones in their two-year partnership to develop a digital endomicroscopic imaging system for robotic surgery, extending their agreement to support further clinical and commercial planning.

Xingye Gold (Hong Kong) Mining Company Limited has launched an off-market takeover offer for all remaining shares in Far East Gold Ltd (ASX:FEG) at $0.13 cash per share, offering shareholders a premium amid stalled projects and funding concerns.